218,420 views
Video Summary: What are Antigen Processing Pathways
Ever wonder how your immune system recognizes the difference between a healthy cell and one infected with flu virus? Antigen processing pathways immunity mechanisms enable this crucial distinction by breaking down foreign proteins into recognizable fragments. For instance, when you receive the annual flu vaccine at your local CVS, these pathways help your dendritic cells present viral fragments to activate your immune response. What are antigen processing pathways exactly, and how do they protect you from disease? Watch the full video on JoVE Coach to master this concept with expert-led visuals and step-by-step explanations.
Antigen processing pathways immunity systems represent sophisticated cellular mechanisms that enable our immune system to survey both internal and external threats. These pathways function as molecular quality control systems, continuously sampling proteins from different cellular compartments and presenting suspicious fragments to immune cells for inspection. Think of them as security checkpoints that screen molecular "identification cards" to distinguish friend from foe.
The endogenous MHC class I pathway operates as your body's internal security system, monitoring what's happening inside every nucleated cell. When cells become infected with viruses like influenza or develop into cancer cells, they produce abnormal proteins that trigger this pathway. The proteasome antigen processing machinery acts like a molecular shredder, breaking down these suspicious proteins into 8-11 amino acid fragments called peptides.
These peptide fragments then travel to the endoplasmic reticulum, where they encounter newly synthesized MHC class I molecules. The peptides bind to these MHC molecules, forming stable complexes that journey to the cell surface. Once displayed on the cell membrane, CD8+ T cells (cytotoxic T lymphocytes) can recognize these foreign peptides and eliminate the compromised cell. This pathway explains why organ transplant patients require immunosuppressive drugs-their immune system recognizes donor tissues as foreign through MHC class I presentation.
Professional antigen-presenting cells, including dendritic cells found in tissues throughout your body, specialize in the exogenous MHC class II pathway. These cellular sentries patrol tissues, capturing external threats like bacteria, fungi, and other pathogens through phagocytosis. Once internalized, pathogens become trapped in specialized vesicles called phagosomes.
The lysosome antigen processing phase begins when lysosomes fuse with these pathogen-containing vesicles, creating acidic environments rich in proteolytic enzymes. These enzymes dismantle pathogens into peptide fragments of 12-25 amino acids. Meanwhile, MHC class II molecules, synthesized in the endoplasmic reticulum, travel in separate vesicles that eventually fuse with the antigen-containing compartments. The resulting MHC II-peptide complexes migrate to the cell surface, where they present foreign antigens to CD4+ T helper cells, initiating adaptive immune responses.
Cross presentation antigen mechanisms allow certain dendritic cells to present extracellular antigens on MHC class I molecules, bridging the gap between these pathways. This process proves crucial for generating immune responses against viruses that don't directly infect antigen-presenting cells and for cancer immunotherapy effectiveness.
Students preparing for the MCAT or AP Biology exams should understand how genetic defects in these pathways cause primary immunodeficiencies, while autoimmune diseases often result from inappropriate antigen presentation. These concepts frequently appear in college immunology courses and medical school curricula, forming the foundation for understanding vaccine mechanisms and therapeutic interventions.
Related Micro-courses